Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 70 years of age who are in generally good to moderate overall health (as rated by a standard medical scale used by anaesthetists)
- People scheduled for a planned kidney transplant where the kidney is coming from a living donor
- People whose anaesthesia plan involves a specific inhaled anaesthetic medication called sevoflurane
- People whose anaesthesia plan involves a combined spinal and epidural technique (a method of numbing the lower body using two types of injections in the back)
Who may not be able to join:
- People younger than 18 or older than 70 years of age
- People receiving a kidney from a deceased (non-living) donor
- People whose anaesthesia plan involves all medications given through a drip rather than inhaled gas
- People who do not wish to take part or are unable to give their own consent to join the study
- People whose overall health is rated as very poor or critically ill on the standard anaesthetist health scale
- People who have previously had an organ transplant of any kind
- People with a known or suspected condition affecting how their cells produce energy (mitochondrial disorders)
- People who have a history of long-term steroid medication use
- People who need a red blood cell transfusion during the operation or within the first 24 hours after surgery
- People where certain time limits related to how long the kidney was without full blood supply were exceeded during the transplant process (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Berna KAYA UĞUR, Doç. Dr., University of Gaziantep
Phone: +90 534 030 89 56
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Serum ferroptosis-related biomarkers (Fe, TFRC1, GPX4, MDA, ACSL4) and mitochondrial-derived peptides (humanin and MOTS-c)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.